The FDA and the Federal Trade Commission are both maintaining potential oversight roles regarding their respective domains.
2 reports, 2 independent
Updated Oct 19
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA and the Federal Trade Commission are both maintaining potential oversight roles regarding their respective domains.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Federal Trade Commission
United States federal government agency
Related events
- The FDA and Department of Health & Human Services are currently collaborating to regulate and shape the use of artificial intelligence in healthcare.
- The FDA is identified as the parent agency of the Department of Health & Human Services (HHS).
- Congress and the Senate are considering legislation affecting FDA submissions and drug patent rights.
- FDA policy proposal affects the operations of AI, Inc.
- Both the FDA and the European Medicines Agency govern drug approval processes.